therapies < therapy < there

Facettes : Author.f AffPays.f AffRegion.f AffVille.f AffOrg.f KwdFr.f Mesh.f MeshFr.f Teeft.f

List of bibliographic references indexed by therapy

Number of relevant bibliographic references: 56.
[0-20] [0 - 20][0 - 50][20-40]

Ident.	Authors (with country if any)	Title
000027 (2020)	Berthold Bein ; Martin Bachmann ; Susanne Huggett ; Petra Wegermann	[SARS CoV-2/COVID-19: Evidence-Based Recommendation on Diagnosis and Therapy].
000085 (2020)	Jin Young Ahn [Corée du Sud] ; Yujin Sohn [Corée du Sud] ; Su Hwan Lee [Corée du Sud] ; Yunsuk Cho [Corée du Sud] ; Jong Hoon Hyun [Corée du Sud] ; Yae Jee Baek [Corée du Sud] ; Su Jin Jeong [Corée du Sud] ; Jung Ho Kim [Corée du Sud] ; Nam Su Ku [Corée du Sud] ; Joon Sup Yeom [Corée du Sud] ; Juhye Roh [Corée du Sud] ; Mi Young Ahn [Corée du Sud] ; Bum Sik Chin [Corée du Sud] ; Young Sam Kim [Corée du Sud] ; Hyukmin Lee [Corée du Sud] ; Dongeun Yong [Corée du Sud] ; Hyun Ok Kim [Corée du Sud] ; Sinyoung Kim [Corée du Sud] ; Jun Yong Choi [Corée du Sud]	Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.
000211 (2020)	Robert Chunhua Zhao [République populaire de Chine]	Stem Cell-Based Therapy for Coronavirus Disease 2019.
000218 (2020)	Daniel Batlle [États-Unis] ; Jan Wysocki [États-Unis] ; Karla Satchell [États-Unis]	Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?
000228 (2020)	Ambra Di Altobrando [Italie] ; Annalisa Patrizi [Italie] ; Federico Bardazzi [Italie]	Should SARS-CoV-2 influence immunosuppressive therapy for autoimmune blistering diseases?
000321 (2020)	Angela Ceribelli [Italie] ; Francesca Motta [Italie] ; Maria De Santis [Italie] ; Aftab A. Ansari [États-Unis] ; William M. Ridgway [États-Unis] ; M. Eric Gershwin [États-Unis] ; Carlo Selmi [Italie]	Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
000418 (2020)	Balamurugan Shanmugaraj [Thaïlande] ; Konlavat Siriwattananon [Thaïlande] ; Kittikhun Wangkanont [Thaïlande] ; Waranyoo Phoolcharoen [Thaïlande]	Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
000448 (2020)	Nicholas D. Brownstone [États-Unis] ; Quinn G. Thibodeaux [États-Unis] ; Vidhatha D. Reddy [États-Unis] ; Bridget A. Myers [États-Unis] ; Stephanie Y. Chan [États-Unis] ; Tina Bhutani [États-Unis] ; Wilson Liao [États-Unis]	Novel Coronavirus Disease (COVID-19) and Biologic Therapy in Psoriasis: Infection Risk and Patient Counseling in Uncertain Times.
000564 (2020)	Ruklanthi De Alwis [Singapour] ; Shiwei Chen [Singapour] ; Esther S. Gan [Singapour] ; Eng Eong Ooi [Singapour]	Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development
000822 (2020)	Qi Zhang [République populaire de Chine] ; Yakun Wang [République populaire de Chine] ; Changsong Qi [République populaire de Chine] ; Lin Shen [République populaire de Chine] ; Jian Li [République populaire de Chine]	Clinical trial analysis of 2019-nCoV therapy registered in China.
000900 (2020)	Thomas P. Lodise [États-Unis] ; Michael J. Rybak [États-Unis]	COVID-19: Important Therapy Considerations and Approaches in this Hour of Need.
000986 (2020)	Mahmoud Yousefifard [Iran] ; Alireza Zali [Iran] ; Kosar Mohamed Ali [Iraq] ; Arian Madani Neishaboori [Iran] ; Afshin Zarghi [Iran] ; Mostafa Hosseini [Iran] ; Saeed Safari [Iran]	Antiviral therapy in management of COVID-19: a systematic review on current evidence
000C14 (2018)	M. Giulietti [Italie] ; A. Righetti [Italie] ; L. Cianfruglia [Italie] ; B. Šabanovi [Italie] ; T. Armeni [Italie] ; G. Principato [Italie] ; F. Piva [Italie]	To accelerate the Zika beat: Candidate design for RNA interference-based therapy.
001112 (2016)	Philipp Kuhn [Allemagne] ; Viola Fühner [Allemagne] ; Tobias Unkauf [Allemagne] ; Gustavo Marcal Schmidt Garcia Moreira [Allemagne] ; André Frenzel [Allemagne] ; Sebastian Miethe [Allemagne] ; Michael Hust [Allemagne]	Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display
001402 (2015)	Rachael S. Felberbaum [États-Unis]	The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors
001437 (2015)		PERFORMANCE OF A PREDICTIVE ALGORITHM IN SENSOR‐AUGMENTED PUMP THERAPY IN THE PREVENTION OF HYPOGLYCAEMIA IN PATIENTS WITH TYPE 1 DIABETES
001462 (2015)		HIGH FLOW NASAL CANNULA OXYGEN (HFNCO) THERAPY FOR BRONCHIOLITIS IN GENERAL PAEDIATRICS
001463 (2015)		HEARING EAR HEALTH AND LANGUAGE SERVICES (HEALS): AN INNOVATIVE PROJECT PROVIDING ENT AND SPEECH THERAPY FOR ABORIGINAL CHILDREN
001828 (2013)	Hisham Momattin [Arabie saoudite] ; Khurram Mohammed [Arabie saoudite] ; Alimuddin Zumla [Royaume-Uni] ; Ziad A. Memish [Arabie saoudite] ; Jaffar A. Al-Tawfiq [États-Unis]	Therapeutic Options for Middle East Respiratory Syndrome Coronavirus (MERS-CoV) – possible lessons from a systematic review of SARS-CoV therapy
001A51 (2013)	A. Gilbey [Nouvelle-Zélande] ; Cm Goertz [États-Unis]	Subject expectancy effect or the effect of chiropractic manipulative therapy?
002071 (2011)	A M Elvis [Inde] ; J S Ekta	Ozone therapy: A clinical review.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "therapy" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "therapy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    therapy
}}

---

This area was generated with Dilib version V0.6.33. Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021